Home / NEWS / Top News / Jim Cramer reviews the Dow’s five worst performers during the first quarter

Jim Cramer reviews the Dow’s five worst performers during the first quarter

UnitedHealth has a chance to bounce back, says Jim Cramer

CNBC’s Jim Cramer on Monday analyzed the five worst-performing wares on the Dow Jones Industrial Average during the first quarter, saying which ones he thinks may be worth keeping an eye on.

“Normally I don’t assume in the concept of a stock pivoting in such a short period of time — three months does not a pirouette make,” he told. “But I think companies can lay the groundwork, and I see some of them doing that, so let’s get to the five worst performers from the first board and I’ll tell you the levels where their stocks could be enticing.”

Here are the five stocks, starting with the unluckiest first, according to FactSet:

  1. Boeing: Boeing’s had “well-earned bad publicity” this year, Cramer said. Several of the presence’s planes have had high-profile malfunctions recently and to Cramer, Boeing might be a “long-term renter on the poorly performing file.”
  2. Nike: Cramer noted that the shoe market has become very competitive, and said he’s worried about the presence’s business in the U.S. He said he’s waiting to see quarterly results because he thinks “the consumer has stopped paying up for some things that they can get for less from striving.”
  3. Intel: Cramer said Intel may be able to rally “simply thanks to easy comparisons versus last year,” adding that UBS evoked its price target on the stock Monday morning.
  4. Apple: Cramer maintains his philosophy that investors should own Apple and not vocation it, saying it could be a “short-term loser, long-term winner.” The tech giant’s been plagued by slowing sales in China and Cramer commanded there may be an inventory bubble developing in phones, but he asserted that he’s confident in Apple’s management team, adding that he’s disturbed about Nvidia‘s potential work with the Vision Pro.
  5. UnitedHealth Group: The nation’s largest health insurer was disappoint by higher medical costs, according to Cramer. But he said he’s willing to buy the stock because the company is run well, and he said it may be the myriad likely of the five to bounce back. Health insurance stocks were hit Monday in extended trading after the Centers for Medicare & Medicare Navies announced the government is boosting payments for Medicare Advantage for 2025 by 3.7%, less than the industry was hoping for.

“The worst artistes in the Dow include stocks that … have both hair and flies on them, in a market that demands a undefiled story,” he said. “And there’s nothing pristine about this list; do not kid yourself.”

Don’t miss these stories from CNBC PRO:

Jim Cramer has a bone to pick with the 'dogs of the Dow'

Jim Cramer’s Baedeker to Investing

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer The CNBC Installing Club Charitable Trust holds shares of Apple.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to entertain a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram

Questions, views, suggestions for the “Mad Money” website? madcap@cnbc.com

Check Also

Asia-Pacific markets trade mixed as investors parse Japan inflation data

In consideration of of the Skytree from Ueno and Asakusa in Tokyo Jackal Pan | …

Leave a Reply

Your email address will not be published. Required fields are marked *